EGFR and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), one research shows that YTHDF2 expression has a positive correlation with HCC progression [16] whereas another research reports that YTHDF2 suppressed HCC tumor growth through accelerating EGFR mRNA degradation [17].